716. Effect of influenza vaccine on Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in older population
Session: Poster Abstract Session: Vaccines
Thursday, October 27, 2016
Room: Poster Hall
Posters
  • IDSA Influenza Poster.pdf (349.1 kB)
  • Background:Annual Influenza immunization is recommended for older adults, though impact of influenza vaccine on inflammatory mediators is not explored. TWEAK is a pro-inflammatory mediator functioning through its receptors (Fn14, CD163) in regulation of inflammation, and fibrosis. In this study, we evaluated the impact of influenza vaccine on TWEAK and its potential predictors.

    Methods:The study was conducted during the 2007-2008 influenza season. We enrolled 69 community-dwelling individuals over 75-year old receiving standard (A/Solomon Islands/3/2006 (H1N1), A/Wisconsin/67/2005 (H3N2), and B/Malaysia/2506/2004) influenza vaccination. Pre and post-vaccination (in 4 weeks) TWEAK and antibody titers against each antigen were measured. The bivariate associations between TWEAK and potential demographic and medical history covariates were examined. We specified a regression model of post-vaccine TWEAK with adjustment for pre-vaccine TWEAK, and the influence of age, gender, hypertension, and frailty status.

    Results:TWEAK level (mean= 690.6, SD= 330.0) significantly decreased after vaccination (mean= 591.7, SD= 290.1) (p= 0.003). Pre and post-vaccination mean CD163 levels were statistically equivalent (p= 0.71). Post-vaccination TWEAK was significantly lower in females (p= 0.01). There were no significant differences in post-vaccination TWEAK according to age, race, frailty status, mini mental status, marital status or history of heart failure, diabetes, heart attack, stroke, angina, or cancer. A time by frailty status interaction term was marginally significant (p= 0.091); decrease in TWEAK was greatest among frail people. A 2-fold antibody titer against H1 antigen was associated with significantly lower TWEAK (p= 0.031) level after vaccination. The effect of H1 antibody titer was not significant after adjustment for pre-vaccine TWEAK level. Mean TWEAK in hypertensive participants was significantly lower compared to those without hypertension (p= 0.04).

    Conclusion: Influenza vaccine could have immune modulatory effect beyond influenza prevention. This effect could potentially be associated with immune response to some vaccine antigens. Future studies investigating this potential beneficial effect are warranted.

    Maryam Keshtkar-Jahromi, MD, MPH1, Min Ouyang, MD2, Marzieh Keshtkarjahromi, MD2, Samah Almed, MS2, Huifen Li, PhD2, Jeremy Walston, MD2, Rebeca Rios, PhD3 and Sean Leng, MD, PhD2, (1)Medicine/ Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, (2)Medicine/Geriatrics, Johns Hopkins University School of Medicine, Baltimore, MD, (3)Biostatistics, Epidemiology, and Database (BEAD) Core; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD

    Disclosures:

    M. Keshtkar-Jahromi, None

    M. Ouyang, None

    M. Keshtkarjahromi, None

    S. Almed, None

    H. Li, None

    J. Walston, None

    R. Rios, None

    S. Leng, None

    See more of: Vaccines
    See more of: Poster Abstract Session
    << Previous Abstract | Next Abstract

    Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.